Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.

Samantha Greenberg | Saundra S Buys | Sandra L Edwards | Whitney Espinel | Alison Fraser | Amanda Gammon | Brent Hafen | Kimberly A Herget | Wendy Kohlmann | Camille Roundy | Carol Sweeney
Cancer medicine | 2019

Personal cancer diagnosis and family cancer history factor into which individuals should undergo genetic testing for hereditary breast and ovarian cancer (HBOC) syndrome. Family history is often determined in the research setting through kindreds with disease clusters, or clinically from self-report. The population prevalence of individuals with diagnostic characteristics and/or family cancer history meeting criteria for HBOC testing is unknown.

Pubmed ID: 31531966

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: Office of Public Health Genomics, International
    Id: DP005360-01
  • Agency: Center for Disease Control and Prevention, International
  • Agency: National Cancer Institute's SEER Program, International
  • Agency: US Center for Disease Control and Prevention's National Program of Cancer Registries, International
  • Agency: University of Utah, International
  • Agency: Huntsman Cancer Foundation, International

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Surveillance Epidemiology and End Results (tool)

RRID:SCR_006902

SEER collects cancer incidence data from population-based cancer registries covering approximately 47.9 percent of the U.S. population. The SEER registries collect data on patient demographics, primary tumor site, tumor morphology, stage at diagnosis, and first course of treatment, and they follow up with patients for vital status.There are two data products available: SEER Research and SEER Research Plus. This was motivated because of concerns about the increasing risk of re-identifiability of individuals. The Research Plus databases require more rigorous process for access that includes user authentication through Institutional Account or multiple-step request process for Non-Institutional users.

View all literature mentions